UVB preferred for treatment of moderate to severe psoriasis

February 24, 2012
UVB preferred for treatment of moderate to severe psoriasis
Ultraviolet B is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March issue of the Journal of the American Academy of Dermatology.

(HealthDay) -- Ultraviolet B (UVB) is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March issue of the Journal of the American Academy of Dermatology.

Joy Wan, of the University of Pennsylvania in Philadelphia, and colleagues surveyed 1,000 U.S. dermatologists, including members of the National Psoriasis Foundation and members of the American Academy of Dermatology who treat psoriasis patients; 387 dermatologists (39 percent) responded.

The researchers found that dermatologists preferred the following therapies for moderate to severe psoriasis for male and , respectively: UVB (40 and 56 percent), (15 and 19 percent), methotrexate (16 and 4 percent), and adalimumab (12 and 10 percent). Among respondents, 66 percent administered phototherapy in their practice. After adjusting for all physician variables, those who preferred first-line UVB for male and female patients were significantly more likely to have phototherapy in their practice (odds ratio [OR], 3.4 and 2.8, respectively) and to have used UVB in more than 10 patients in the last three months (OR, 8.0 and 9.6, respectively). in the Midwest were more likely than those in the Northeast to prefer as first-line therapy for moderate to severe psoriasis for male and female patients.

"UVB is most commonly preferred as a first-line treatment for moderate to severe psoriasis in healthy adults, and preferences vary based on region, phototherapy availability, and prior treatment use," the authors write.

Several authors disclosed to pharmaceutical companies.

Explore further: Patients with severe psoriasis need evaluation of heart disease risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

New clinical study probes how light fights psoriasis

April 29, 2009

Ultraviolet light is a proven treatment for psoriasis, one of humanity’s oldest known diseases. Sunshine can also beat back the chronic autoimmune disorder of the skin. But explaining light’s therapeutic effects has been ...

Recommended for you

Zika virus may persist in the vagina days after infection

August 25, 2016

The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

In sub-Saharan Africa, cancer can be an infectious disease

August 26, 2016

In 1963, Irish surgeon Denis Parson Burkitt airmailed samples of an unusual jaw tumor found in Ugandan children to his colleague, Anthony Epstein, at Middlesex Hospital in London. Epstein, an expert in chicken viruses and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.